Amongst various IL-1 polymorphisms, IL-1β-511C/T promoter has shown promising susceptibility in the progression of inflammatory disorders such as RA and SLE [15,16] and juvenile idiopathic arthritis as well [17]; however, evidence on the association with CCS is still lacking. Here, IL1B is linked to systemic lupus erythematosus.